Delivery system established for oral and inhalation.
Efficacy well established for pathogens – bacteria, virus, fungal
No likelihood of resistance. Succesful study in URT – around 80% efficacy. 3 Sepsis patinets cured of infection in 3 days.
- Infection prevention
- Antimicrobial compounds
- Market entry
- License, Joint Venture
Development and manufacture of bio-identical active anti-microbials.
Potential in animal and humans, also for clean air and agriculture.